Fast-Track Colorectal Surgery in Senior Patients (FT-SS)

July 20, 2012 updated by: Sandrine Ostermann, University Hospital, Geneva

Fast-Track Perioperative Care After Elective Colorectal Surgery in Senior Patients. Randomized Controlled Trial

Fast-track (FT) surgery is a multimodal, multidisciplinary-team approach to reduce perioperative surgical stress and injury after colorectal surgery, resulting in lower morbidity and enhanced recovery. As fast-track approach could probably be the most beneficial for senior patients to reduce postoperative morbidity and better preserve independency, only scarce information is available in senior population. Therefore a randomized controlled trial is initiated in our institution compare a senior dedicated fast-track approach to modern standard care after colorectal surgery.

Study Overview

Detailed Description

BACKROUND:

The multimodal concept of fast-track (FT) surgery was developed by Kehlet et al. in the 1990s to reduce perioperative surgical stress after colorectal surgery, resulting in lower morbidity & mortality and enhanced recovery.

The main evidence-based FT components include: pain control optimization by epidural or systemic analgesia, short-acting anesthetics, opioids-sparing analgesia, minimally invasive surgery, preoperative carbohydrate administration, normothermia preservation, individualized i.v goal-directed fluids therapy, no bowel preparation, no routine use of drains, nasogastric tube, urinary catheters, early oral nutrition and active ambulation, as well as a dedicated preoperative counseling defining the FT clinical pathway and discharge criteria.

Many cohort studies, randomized controlled trials, meta-analyses and systematic reviews have demonstrated its safety and efficacy for decreasing morbidity, hospital stay, and improving patient satisfaction as compared to standard care (SC).

Only scarce information, mainly based on RetroPro or controlled clinical trials (CCTs), is available on fast-track perioperative care in senior patients (>70 years) as they already represent 15-18% of western population, and over 40% of colorectal surgeries performed at Geneva University Hospital (HUG).

The aim of this randomized controlled trial (RCT) is to compare short-term clinical outcomes of a specifically senior designed fast-track perioperative program versus standard care (SC) after elective colorectal surgery in senior patients.

OBJECTIVES:

30-day postoperative morbidity according to Dindo-Clavien classification of complication is the primary clinical endpoint.

Length of hospital stay (LOS) including readmission, autonomy preservation (through the activities of daily living (ADLs) and instrumental activities of daily living (IADL) scale) and quality of life evaluation are secondary endpoints.

METHOD:

All patients over 70 years requiring elective colorectal surgery will be included in this study after given written informed consent. Exclusion criteria consisted in emergency revisional or liver-associated surgery, and inability to discern/speak French or English. Patients will be 1:1 randomized (institutional table of randomization.

Study Type

Interventional

Enrollment (Anticipated)

150

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Geneva, Switzerland, 1211
        • Recruiting
        • University Hospital, Geneva
        • Contact:
        • Contact:
        • Principal Investigator:
          • Sandrine Ostermann, MD, PhD
        • Sub-Investigator:
          • Philippe Morel, Pr

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

70 years and older (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • senior patients (> or = 70 years at operation)
  • elective colorectal surgery

Exclusion Criteria:

  • emergency, liver-associated, revisional surgeries
  • inability to discern or speak French/English, dementia
  • absolute contraindication to systemic analgesia (severe allergic reaction)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Standard care
Preoperative: Fasting state after midnight, no intake of oral carbohydrate load Preanesthetic medication No preoperative utilization of inspirex Intraoperative: Effective perioperative analgesia Routine nasogastric tube and abdominal drainage at surgeon discretion Postoperative: Removal of the nasogastric tube after return of bowel function removal of abdominal drainage at surgeon discretion or if volume <50cc Oral liquids and stepwise oral nutrition (water to others liquids to progressive normal or low-fiber nutrition Switch to oral medication after oral nutrition tolerance Urinary catheter removal when the mobilization is satisfactory Mobilization: non standardized and encouraged stepwise mobilization Discharge criteria discussed at surgeon discretion
No preoperative glucose load
Preanesthetic oral medication before surgery
Experimental: FT perioperative care
Preoperative carbohydrate load No preanesthetic medication General anesthesia and intravenous analgesia Transoesophageal US-Doppler for individualized i.v fluids therapy POD 0: No Nasogastric tube postoperatively Oral liquids 0.3-0.5L 6h after extubation First mobilization 6h after surgery (2h) Stimulation of inspirex utilization (6-8t/d) POD 1: Free oral liquids; progressive normal or low-fiber diet Switch to oral medication Urinary catheter removal Mobilization: >4 h out of bed (walking, chair) inspirex utilization POD 2: Free oral liquids; normal or low-fiber diet Mobilization: >6 h out of bed (walking, chair), inspirex utilization POD 3: Complete mobilization as preoperatively First evaluation of discharge criteria in the afternoon
oral intake in the evening before surgery and 2-3h before intubation
by Transoesophageal aortic US-Doppler done intraoperatively
Withdrawal after complete awakening in operating room
at POD 1
0.3-0.5L oral liquids at 6h postoperatively on POD 0
using 6-8 times/day to prevent pulmonary atelectasis
First active mobilization 6h after surgery (2h on chair or 45° sitting in bed), >4h out of bed on POD1, >6h on POD2, complete at POD3

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
30-day morbidity according to Dindo-Clavien classification
Time Frame: Postoperative day (POD) 0 to 30
Dindo-Clavien classification of postoperative complication (Grade I to V), including mortality (grade V)
Postoperative day (POD) 0 to 30

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Length of hospital stay (LOS)
Time Frame: discharge day
LOS: from operating date to discharge
discharge day
quality of life (QoL)
Time Frame: POD 0, 30 at 6 and 12 months
QoL using a validated questionnaire for digestive surgery (SF-12) 0 to 44 points for 7 items
POD 0, 30 at 6 and 12 months
readmission
Time Frame: until POD 30
readmission in any hospital for any reason during the 30 postoperative days
until POD 30
Level of independance
Time Frame: POD 0, 30, at 6 and 12 months
using geriatric functional scale: ADLs(0-6), IADLs (0-7)scoring
POD 0, 30, at 6 and 12 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain evaluation
Time Frame: POD 0 at 6h and 24h, POD 2, POD 3
Pain score through visual analogue scale (VAS)
POD 0 at 6h and 24h, POD 2, POD 3
Fatigue évaluation
Time Frame: POD 0 at 6h and 24h, POD 2, POD 3
Fatigue measured through numeric scale:0 (no fatigue) to 3 (severe) fatigue
POD 0 at 6h and 24h, POD 2, POD 3

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Sandrine Ostermann, MD, PhD, University Hospital, Geneva

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2009

Primary Completion (Anticipated)

December 1, 2013

Study Completion (Anticipated)

December 1, 2013

Study Registration Dates

First Submitted

July 18, 2012

First Submitted That Met QC Criteria

July 19, 2012

First Posted (Estimate)

July 20, 2012

Study Record Updates

Last Update Posted (Estimate)

July 23, 2012

Last Update Submitted That Met QC Criteria

July 20, 2012

Last Verified

July 1, 2012

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Colorectal Disorders

Clinical Trials on Fasting state after midnight

Subscribe